OCAMPO CHRISTINE
Insider CIK 1280154 · NVUS See Remarks · UROV PFAO;CAO/Urovant Sciences,Inc. · AVNR Vice President, Finance
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| UROV Urovant Sciences Ltd. | D To issuer deriv | 2021-03-29 | 2021-03-31 | 3,750 | — | $0 | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | D To issuer deriv | 2021-03-29 | 2021-03-31 | 133,500 | — | $0 | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | D To issuer deriv | 2021-03-29 | 2021-03-31 | 70,000 | — | $0 | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | D To issuer | 2021-03-29 | 2021-03-31 | 9,810 | — | $0 | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | D To issuer | 2021-03-29 | 2021-03-31 | 68,971 | — | $0 | 0 | SEC↗ |
| UROV Urovant Sciences Ltd. | A Award | 2020-05-01 | 2020-05-04 | 44,346 | — | $0 | 77,179 | SEC↗ |
| UROV Urovant Sciences Ltd. | A Award | 2020-01-07 | 2020-01-09 | 32,833 | — | $0 | 32,833 | SEC↗ |
| UROV Urovant Sciences Ltd. | A Award deriv | 2019-01-06 | 2019-01-08 | 70,000 | — | $0 | 70,000 | SEC↗ |
| UROV Urovant Sciences Ltd. | A Award deriv | 2018-10-15 | 2018-10-17 | 3,750 | — | $0 | 3,750 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award deriv | 2017-05-24 | 2017-05-26 | 52,500 | — | $0 | 52,500 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | P Buy | 2017-05-10 | 2017-05-11 | 10,010 | $9.99 | $100.0K | 21,590 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | S Sale | 2014-12-18 | 2014-12-18 | 5,780 | $16.93 | $97.9K | 108,797 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | M Exercise deriv | 2014-12-16 | 2014-12-18 | 17,500 | — | $0 | 0 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | M Exercise deriv | 2014-12-16 | 2014-12-18 | 12,500 | — | $0 | 17,500 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | M Exercise | 2014-12-16 | 2014-12-18 | 12,500 | $2.59 | $32.4K | 127,077 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | M Exercise | 2014-12-16 | 2014-12-18 | 17,500 | $4.18 | $73.2K | 144,577 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | S Sale | 2014-12-16 | 2014-12-18 | 12,500 | $16.94 | $211.8K | 132,077 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | S Sale | 2014-12-16 | 2014-12-18 | 17,500 | $16.94 | $296.4K | 114,577 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2014-11-10 | 2014-11-12 | 19,844 | — | $0 | 114,577 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2014-11-10 | 2014-11-12 | 31,992 | — | $0 | 94,733 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | S Sale | 2014-10-24 | 2014-10-24 | 2,080 | $11.81 | $24.6K | 77,791 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | M Exercise deriv | 2014-09-15 | 2014-09-17 | 55,000 | — | $0 | 17,500 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | S Sale | 2014-09-15 | 2014-09-17 | 55,000 | $9.45 | $519.7K | 79,871 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | S Sale | 2014-08-26 | 2014-08-28 | 2,110 | $6.10 | $12.9K | 79,871 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | S Sale | 2014-05-16 | 2014-05-16 | 11,900 | $4.88 | $58.1K | 3,000 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | S Sale | 2014-05-14 | 2014-05-16 | 25,596 | $5.13 | $131.3K | 81,981 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2014-02-12 | 2014-02-14 | 15,050 | — | $0 | 107,577 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2014-02-12 | 2014-02-14 | 29,325 | — | $0 | 92,527 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | S Sale | 2013-12-18 | 2013-12-20 | 2,450 | $2.63 | $6.4K | 63,202 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award deriv | 2013-12-13 | 2013-12-17 | 17,250 | — | $0 | 17,250 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | M Exercise deriv | 2013-05-15 | 2013-05-17 | 38,700 | — | $0 | 0 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | M Exercise deriv | 2013-05-15 | 2013-05-17 | 4,000 | — | $0 | 0 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | M Exercise deriv | 2013-05-15 | 2013-05-17 | 15,000 | — | $0 | 0 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | S Sale | 2013-05-15 | 2013-05-17 | 57,700 | $3.28 | $189.3K | 65,652 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | S Sale | 2013-05-15 | 2013-05-17 | 20,000 | $3.29 | $65.8K | 65,652 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | M Exercise | 2013-05-15 | 2013-05-17 | 4,000 | $0.88 | $3.5K | 69,652 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | M Exercise | 2013-05-15 | 2013-05-17 | 38,700 | $0.88 | $34.1K | 123,352 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | M Exercise | 2013-05-15 | 2013-05-17 | 15,000 | $0.88 | $13.2K | 84,652 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award deriv | 2012-12-17 | 2012-12-19 | 32,500 | — | $0 | 32,500 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2012-12-17 | 2012-12-19 | 21,288 | — | $0 | 76,689 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | A Award | 2012-12-17 | 2012-12-19 | 8,963 | — | $0 | 85,652 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | S Sale | 2012-12-03 | 2012-12-05 | 2,845 | $2.55 | $7.3K | 55,401 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | M Exercise deriv | 2012-09-17 | 2012-09-19 | 65,000 | — | $0 | 65,000 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | S Sale | 2012-09-17 | 2012-09-19 | 65,000 | $3.49 | $226.8K | 58,246 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | M Exercise | 2012-09-17 | 2012-09-19 | 65,000 | $0.53 | $34.5K | 123,246 | SEC↗ |
| AVNR AVANIR PHARMACEUTICALS, IN | P Buy | 2012-03-06 | 2012-03-07 | 3,000 | $2.60 | $7.8K | 3,000 | SEC↗ |